Immunomodulation by Hemoadsorption-Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock : a prospective study.
Pubblicato in: | Biomedicines 10(2022)10, S. 2340 |
---|---|
Autori principali: | Praxenthaler, Janina (Autore), Schwier, Elke (Autore), Altmann, Simon (Autore), Kirchner, Carmen (Autore), Henzler, Dietrich (Autore), Köhler, Thomas (Autore) |
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
2022
|
Soggetti: | |
Accesso online: | https://pubmed.ncbi.nlm.nih.gov/36289602/ https://doi.org/10.3390/biomedicines10102340 |
Documenti correlati: | In:
Biomedicines |
Documenti analoghi
-
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
di: Köhler, Thomas, et al.
Pubblicazione: (2022) -
Case report: Early detection of mesenteric ischemia by intravital microscopy in a patient with septic shock
di: Praxenthaler, Janina, et al.
Pubblicazione: (2022) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
di: Schultz, Philipp, et al.
Pubblicazione: (2021) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
di: Köhler, Thomas, et al.
Pubblicazione: (2021) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
di: Schwier, Elke, et al.
Pubblicazione: (2021)